ABBV
AbbVie Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 12:24 UTC
Last close
288.24USD
Market data, 2026-11-05
Except where said otherwise: 10-K for 2025, filed 2026-02-20
122.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
16.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
6.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
29.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
2.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-20
Price is the furthest below its sector's middle: 0.10 against 0.33 on the market's range.
Six questions
lens 5 of 9Six questions
4 yes of 5 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?Not known
share count change yoy, read below 1. We do not hold that figure for this company.
- 6Is it priced under twenty times earnings?no
pe ratio, read below 20.
1 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.
4 of 5 questions answered yes; 1 could not be answered.
4 of 5 questions answered yes; 1 could not be answered.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-20
Does it earn money?6.9%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Can it pay what it owes?5.2x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Is it bigger than five years ago?6.0%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Does the profit turn into cash?29.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Is it issuing shares?n/a
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Is it priced under twenty times earnings?122.9x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD